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CURRENT LITER ATURE
Treatment of malnourished CAPD
patients with an amino acid based
dialysate
JD KOPPLE, D BERNARD, J MESSANA, ET AL
Harbor-UCLA Medical Center, California; University Hospital,
Boston; University of Michigan, Ann Arbor; Karolinska Institute,
Huddinge, Sweden; University of Iowa, Iowa City; Washington
University, St. Louis; Baxter Healthcare, McGaw Park, Illinois
ABSTRACT: Nineteen malnourished chronic peritoneal dialy-
sis patients who were ingesting a low protein intake underwent
metabolic balance studies to test whether a dialysate that
contained amino acids would improve their protein nutrition.
Patients lived in the hospital for 35 days while they ate a
constant diet and underwent their usual regimen of continuous
ambulatory peritoneal dialysis (CAPD). The first 15 days served
as a Baseline Phase. For the last 20 days, the usual dialysate was
substituted with a dialysate of essentially the same composition
except that it contained 1.1% essential and nonessential amino
acids and no glucose. Patients received one or two dialysate
exchanges with amino acids each day depending on the amount
necessary to bring the individual’s dietary protein plus dialysate
amino acid intake to 1.1 to 1.3 g/kg body weight/day. During
Baseline, patients were in neutral nitrogen balance; net protein
anabolism was positive, as determined from 15 N-glycine stud-
ies. After commencing intraperitoneal amino acid therapy, ni-
trogen balance became significantly positive, there was a signifi-
cant increase in net protein anabolism, the fasting morning
plasma amino acid pattern became more normal, and serum
total protein and transferrin concentrations rose. Patients gen-
erally tolerated the treatment well, although some patients
developed mild metabolic acidemia. These findings indicate that
a dialysate containing amino acids may improve protein malnu-
trition in CAPD patients ingesting low protein intakes. (Kidney
Int 1995;47:1148-57)
COMMENT: This strong piece of research overcomes the
limitations of previous studies of the effects of amino acid-
based dialysate for CAPD patients by (1) selecting a popu-
lation of patients who clearly were malnourished and (2)
following them metabolically for an extended period. The
definition of malnutrition included evidence for muscle
wasting, body weight < 90% desirable or serum albumin <
normal, and inadequate dietary protein intake. The popu-
lation thus selected should represent patients with existing
malnutrition and no expectation of correction of protein
deficits by dietary means alone. In fact, the mean body
weight relative to desirable body weight was 91 +/- 13%,
and 11 of the 19 patients were < 86% of desirable body
weight. The mean albumin concentration was 3.6 g/dL with
a range of 2.3 to 3.9. All but one of the 19 patients had
multiple objective signs of malnutrition.
The patients received a stable dietary intake and their
usual CAPD regimen for 15 days, and then followed with
the amino acid treatment regimen. It is not clear that either
the patients or the investigators were blinded to the treat-
ment given. Unfortunately, all patients received Baseline
Phase treatment first followed by Treatment Phase, leav-
ing the results open to confounding by time-treatment
interactions. The small sample size also leaves the possibil-
ity of a Type II statistical error in some results, and no
power statistics are calculated.
The increases in transport proteins are not unexpected.
Albumin, with its 21-day half-life, did not change signifi-
cantly over the treatment period, while transferrin, with its
14-day half-life, did. The nitrogen balance studies covered 9-
day periods at the end of each phase, and allowed 6 to 11 days
for adjustment to the level of protein intake before nitrogen
balance began. The mean nitrogen balance during the
Baseline Phase was +0.5 g/day and + 1.71 g/day in the
Treatment Phase, a significant difference. Nitrogen intake
increased from 8.32 g/day duringBaseline to 13 g/day during
Treatment as a result of the l.l% amino acid dialysate.
Sixteen of the 19 subjects underwent protein turnover stud-
ies, which showed no difference in protein degradation but a
significant increase in net anabolism.
In general, the amino acid solutions were well-tolerated
by patients. One undesirable side effect was a mild meta-
bolic acidosis (decrease in the serum carbon dioxide concen-
tration from 25 to 21). Arterial blood gas measurements on
seven patients, however, documented normal pH.
This study represents an important treatment option for
clinically stable but malnourished end-stage renal disease
patients with CAPD as their dialysis treatment modality.
While the increase in protein intake may appear limited
(mean of 29 g/day) relative to usual TPN levels of intake,
malnourished subjects responded favorably over a timeframe
of 20 days.
Charlene Compher, MS, RD, CNSD
Small bowel necrosis associated with
postoperative jejunal tube feeding
CD SCHUNN, JM DALY
University of Pennsylvania School of Medicine, Philadelphia
ABSTRACT: Background: Postoperative enteral nutrition us-
ing jejunal tube feeding is widely practiced and usually well
tolerated. Functional intestinal complaints occur frequently but
generally respond to alteration of the infusion rate or tube
feeding formula. Occasionally, however, nonspecific signs of
intestinal disturbance progress to a syndrome of abdominal
distention, hypotension, and hypovolemic shock resulting in
extensive small bowel necrosis. Study design: During a six-year
period, four patients have been identified retrospectively who
had this complication among 1,359 patients receiving jejunal
tube feeding. Their clinical course was evaluated critically and
compared with 11 cases described in the literature. Results:
Small bowel necrosis is a rare but highly morbid complication
associated with postoperative jejunal tube feeding. Of 14 pa-
tients who had small bowel necrosis develop, 12 succumbed to
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this complication. The causative mechanism remains unclear, but
is most likely the result of several factors. Conclusions: Tube
feeding should be discontinued immediately and total parenteral
nutrition should be considered in patients who have abdominal
pain, abdominal distention, increased nasogastric drainage, and
signs of intestinal ileus. (J Am Coll Surg 1995;180:410-6)
COMMENT: Small bowel necrosis, a rare but highly morbid
clinical condition, is associated with jejunal tube feedings.
When to discontinue tube feedings to prevent small bowel
necrosis is an important question. Unfortunately, the mecha-
nism of action has not been determined. The authors sug-
gested that low mesenteric blood flow during stress or direct
mucosal injury are possible causes. Small bowel necrosis does not
have any specific signs or symptoms to indicate when to discon-
tinue enteral feeding. The clinical presentation is difficult to
distinguish from other tube feeding problems, which makes the
decision to discontinue enteral feedings and possibly begin
parenteral nutrition difficult.
The importance of early enteral feedings is well estab-
lished as it is associated with less septic morbidity and
fewer infections than parenteral nutrition. Additionally,
literature supporting early nutrition has shown improve-
ment in nitrogen balance, serum albumin, and clinical
outcomes. The importance of early enteral feeding cannot
be overstated and early discontinuation could compromise
patient care. Similarly, feeding a patient with small bowel
necrosis would be detrimental.
The authors suggest the discontinuation of tube feedings
when the patient presents with abdominal distention, ab-
dominal pain, increased nasogastric drainage, and signs of
intestinal ileus. This recommendation may be appropriate for
some patients, though each patient must be individually
assessed. The presentation of these symptoms in the early fed
patient versus the chronically fed patient might be handled
differently. In some settings, early fed patients presenting
with these symptoms would have their tube feedings discon-
tinued, whereas chronically fed patients might be closely
monitored without immediate discontinuation oftube feedings.
Furthermore, patients should not receive tube feedings if they
are hemodynamically unstable, which includes those receiv-
ing crystalloid resuscitation or pressor agents.
In conclusion, when the symptomatology and conditions
for small bowel necrosis are suspected, jejunal tube feedings
should be discontinued. Unfortunately, some symptoms of
small bowel necrosis are not unique and may be indicators
of a more benign problem; early discontinuation of enteral
feedings may compromise patient care in such cases. Each
patient must be clinically assessed and other causes ruled
out before enteral nutrition is stopped.
Jane Gervasio, PharmD
A prospective study evaluating the
effects of extending total parenteral
nutrition line changes to 72 Hours
G ROBATHAN, S WOODGER, D MERANTE
Princess Margaret Hospital, Perth, Australia
ABSTRACT: The use of total parenteral nutrition (TPN) has
increased considerably in recent years, resulting in greater
demands on human and material resources. Current practice in
most hospitals is to replace IV lines for TPN every 24 hours,
whereas all other IV lines are changed every 72 hours. A
prospective study was conducted in a pediatric hospital to
compare the nosocomial infection incidence between 24- and 72-
hour TPN line changes. The convenience sample of 279 patients
receiving TPN was studied over two consecutive 12-month peri-
ods. A statistically significant decrease was found in the inci-
dence of nosocomial septicemia in the 72-hour line change group.
A substantial decrease also was demonstrated in the overall cost
of TPN management. (J Intravenous Nurs 1995;18:84-7)
COMMENT: Detailed guidelines have been developed to
reduce the risk of bloodstream infection in patients receiv-
ing IV therapy. Initially, administration sets were univer-
sally changed every 24 hours. In 1980 the Centers for
Disease Control and Prevention recommended a 48-hour
replacement of administration sets for all IV infusions
except TPN.’ In 1987 Maki et al concluded that extrinsic
contamination of IV fluids is a rare cause of nosocomial
septicemia and recommended a routine 72-hour replace-
ment of IV delivery systems for most infusions including
TPN.2 2
The present study compared the incidence of catheter-
related infections in TPN pediatric patients undergoing
tubing changes on a 24- or 72-hour schedule and supports
the earlier findings of Maki et al, as the authors had
hypothesized there was no increase in infection when tub-
ing changes were extended to 72 hours. Interestingly, how-
ever was the significant decrease in IV-related septicemia
in the group receiving the 72-hour tubing changes, which
was postulated to be related to the decrease in hub manipu-
lation. The TPN formulations were not identified, and
therefore it is unclear whether patients were receiving
continuous fat as in a total nutrient admixture or a dex-
trose/amino acid based solution, which may be an impor-
tant variable. This study has direct implications for infec-
tion control and cost savings in the clinical setting.
Elizabeth Krzywda BSN, RN, CNSN
1. Centers for Disease Control Working Group: Guidelines for
prevention of intravascular therapy-related infections. In-
fect Control 1981;3;62-79.
2. Maki DG, Boticelli JT, LeRoy ML, et al: Prospective study of
replacing administration sets for intravenous therapy at 48-
vs 72-hour intervals. JAMA 1987;258:1777-81.
Improving central placement rates of
peripherally inserted catheters
GD LARUE
Kusler’s Option Care, Everett, Washington
ABSTRACT: Recent advances in catheter technology and in the
knowledge base of professionals in the practice of intravenous
therapy have had a significant impact on patient care and
improved outcomes. As professionals learn new techniques and
monitor outcomes, they appropriately begin to question some
traditional beliefs. One of the items that we monitor in our
continuous quality improvement program is the number of
malpositioned peripherally inserted central catheters immedi-
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